Written answers

Tuesday, 25 February 2014

Department of Health

Medicinal Products Licensing

Photo of Seán Ó FearghaílSeán Ó Fearghaíl (Kildare South, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

634. To ask the Minister for Health the total number of serious adverse reactions to Lariam, using the strict medical definition of "serious", reported to the Irish Medicines Board, where the symptoms have persisted for less than a year, where symptoms have persisted for more than one year but less than three, where symptoms have persisted for more than three years but have now resolved, and where symptoms have persisted for more than three years, have still not resolved and where a serious adverse reaction was reported but the IMB has no follow-up data on whether these symptoms persist or have resolved; and if he will make a statement on the matter. [8896/14]

Photo of James ReillyJames Reilly (Dublin North, Fine Gael)
Link to this: Individually | In context | Oireachtas source

The Irish Medicines Board is the statutory body responsible for the authorisation of marketing permission for pharmaceutical products and the monitoring of possible adverse reactions to such products. Therefore, I have asked the IMB to reply directly to the Deputy in this regard.

Comments

No comments

Log in or join to post a public comment.